| # | Drug | Count |
|---|---|---|
| 0 | AMBRISENTAN | 807 |
| 1 | SILDENAFIL CITRATE | 461 |
| 2 | ASPIRIN | 412 |
| 3 | MACITENTAN | 411 |
| 4 | TADALAFIL | 395 |
| 5 | TREPROSTINIL | 391 |
| 6 | ASPIRIN 325 MG | 381 |
| 7 | ASPIRIN 81 MG | 381 |
| 8 | FUROSEMIDE | 317 |
| 9 | SILDENAFIL | 290 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BACITRACIN AND POLYMYXIN B SULFATE | 1 | 0.0667 |
| 1 | APROCITENTAN | 1 | 0.0455 |
| 2 | EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE | 3 | 0.0242 |
| 3 | NEFAZODONE HYDROCHLORIDE | 2 | 0.0165 |
| 4 | RANOLAZINE | 101 | 0.0096 |
| 5 | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | 2 | 0.0094 |
| 6 | SELEXIPAG | 233 | 0.0089 |
| 7 | EPOPROSTENOL | 107 | 0.0082 |
| 8 | CHLOROTHIAZIDE | 10 | 0.0079 |
| 9 | ILOPROST | 7 | 0.0075 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 1205 |
| 1 | Phosphodiesterase 5 Inhibitor [EPC] | 577 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 519 |
| 3 | Prostacycline Vasodilator [EPC] | 479 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 416 |
| 5 | Loop Diuretic [EPC] | 388 |
| 6 | Factor Xa Inhibitor [EPC] | 249 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 233 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 219 |
| 9 | Soluble Guanylate Cyclase Stimulator [EPC] | 218 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 13 | 0.0189 |
| 1 | Lead Chelator [EPC] | 1 | 0.0119 |
| 2 | Anti-anginal [EPC] | 101 | 0.0096 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 233 | 0.0089 |
| 4 | Prostacycline [EPC] | 7 | 0.0075 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 218 | 0.0064 |
| 6 | Endothelin Receptor Antagonist [EPC] | 1205 | 0.0060 |
| 7 | PCSK9 Inhibitor [EPC] | 153 | 0.0059 |
| 8 | Provitamin D2 Compound [EPC] | 163 | 0.0055 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 10 | 0.0048 |